Clinical Trials Logo

Smoking Behaviors clinical trials

View clinical trials related to Smoking Behaviors.

Filter by:

NCT ID: NCT05460650 Completed - Breast Cancer Clinical Trials

Acceptance and Usability of an App Promoting Healthy Behaviours Amongst Young Women at Increased Risk of Breast Cancer

Start date: November 3, 2022
Phase: N/A
Study type: Interventional

It is estimated that around 20% of breast cancers (BC) in the UK are preventable through adherence to appropriate health behaviours, i.e., healthy diet, physical activity, limited alcohol, not smoking, and that women at increased risk of BC could benefit from greater decreases in risk than the general population via health behaviour changes. Young women (age <35 years) who are at increased risk of developing BC currently receive little or no information regarding health behaviours and BC risk, or support for behaviour change. This feasibility study aims to explore whether a novel app is acceptable to women at increased risk and could potentially engage them with improved health behaviours which could reduce their future risk of BC.

NCT ID: NCT05442294 Not yet recruiting - Adolescent Behavior Clinical Trials

"Juego de LLaves": Study Protocol of a Universal School-based Drug Use Prevention Program (PSIDUP)

PSIDUP
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

"Juego de Llaves" is a universal school-based drug prevention program for adolescents aged 12-15 years. The outcome evaluation is critical to determine the quality of preventive interventions. This protocol describes the full protocol of the evaluation design, instruments, randomization procedure, follow-ups, and primary outcomes. Method: Non-Randomized Control Cluster Trial in a set of Spanish school centers at the compulsory secondary education level, with follow-ups at 12-, 24- and 36-months. Participants will be allocated to an experimental or control (no intervention) group. Using an electronic ad-hoc designed App, a battery of instruments will be used to assess addictive behaviors, sociodemographic variables, school climate and other transdiagnostic psychological variables. A piloting test will be conducted to test the implementation protocol and to calculate the sample size needed for the outcome evaluation. After implementing the program, longitudinal statistical approaches will be used to inform on the intervention efficacy and potential moderators and mediators. There is a lack of effectiveness assessments of school prevention programs, and it is expected that this protocol will expedite the monitoring and ongoing evaluation in prevention.

NCT ID: NCT05426460 Active, not recruiting - Smoking, Cigarette Clinical Trials

AAT + tDCS to Reduce Cue-induced Craving and Smoking Behavior

Start date: April 29, 2022
Phase: N/A
Study type: Interventional

Smokers are highly reactive to smoking-related stimuli and report that this cue reactivity (CR) is a major obstacle to quitting. To date, no pharmacologic methods attenuate CR, and attempts to diminish it with traditional cue exposure treatment (CET) have not proven effective. The proposed study will test a highly novel cue-based smoking treatment adjunct combining an Approach/Avoidance Task (AAT) with brain stimulation via tDCS applied to the dorsolateral prefrontal cortex (dlPFC) during personalized multi-cue exposure; the goal of which is to discover an effective means of reducing cue reactivity and daily smoking, and increasing intent and confidence to quit, among high treatment-interest smokers.

NCT ID: NCT05370859 Completed - Cancer Clinical Trials

mMe: Motivational Monitoring to Enhance Smoking Cessation Among Cancer Patients

mMe
Start date: July 18, 2022
Phase:
Study type: Observational

The objectives of this study are to pilot test a protocol of weekly assessments of motivation to quit and other relevant constructs combined with information about how to enroll in cessation programs, which will allow initial quantification of motivation to quit during cancer treatment and develop hypotheses about the impact of motivation on the decision to enroll in services.

NCT ID: NCT05308459 Active, not recruiting - Physical Inactivity Clinical Trials

Data Health VET - Data-driven Health Promotion at Vocational Education and Training Schools

Start date: January 19, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effectiveness of a data driven and dynamic systems approach at Danish Vocational schools to promote student health behavior and wellbeing and school organizational readiness.

NCT ID: NCT05307822 Completed - Smoking Clinical Trials

CSD210903: A Study to Determine Subject Puffing Patterns of a Heated Tobacco Product With Four Non-Combusted Cigarette Variants in an Ambulatory Setting

Start date: April 21, 2022
Phase: N/A
Study type: Interventional

This is a multi-center, open-label, parallel-cohort-study to evaluate the puffing patterns of healthy adult consumers of tobacco products switching from a usual brand (UB) combustible cigarette (CC) and/or a UB Heated Tobacco Product (HTP) to one of four investigational products (IPs), across two heating modes, over a 28-day ambulatory period.

NCT ID: NCT05231421 Active, not recruiting - Smoking Cessation Clinical Trials

A Focus Group Study to Explore Smoking Triggers and Acceptability of Just-in-time Adaptive Intervent

Start date: January 18, 2020
Phase:
Study type: Observational

This research intends to identify common smoking triggers and barriers to quitting smoking; understand useful and effective strategies for smoking cessation; and explore the feasibility and acceptability of mobile phone-based interventions among low-income smokers.

NCT ID: NCT05210699 Completed - Smoking Clinical Trials

CSD201201: Study to Assess Elements of Abuse Liability for Electronic Nicotine Delivery System P12

Start date: March 21, 2022
Phase: N/A
Study type: Interventional

This is a randomized, open-label, 6-way crossover, multi-site study designed to evaluate elements of abuse liability (AL) including subjective effects and physiological measures (pharmacodynamics [PD]), and nicotine uptake (pharmacokinetics [PK]) during and following ad libitum use of the Electronic Nicotine Delivery Systems (ENDS) investigational products (IPs) in generally healthy combustible cigarette (CC) smokers and dual users of CC and ENDS.

NCT ID: NCT05157048 Completed - Smoking Behaviors Clinical Trials

Acute Cigarette Evaluation Study

SKY Pilot
Start date: March 10, 2022
Phase: N/A
Study type: Interventional

This single laboratory session pilot study will examine the acute effects of commercially available cigarettes on adult smokers' initial product perceptions, use, and exposure. Forty adult daily smokers will be randomized to smoke two study-supplied commercially-available cigarettes interspersed by 45 minutes, completing pre- and post-cigarette carbon monoxide and questionnaire measures.

NCT ID: NCT05114863 Completed - Smoking Clinical Trials

CSD200907: A Study to Assess Elements of Abuse Liability for a Heated Tobacco Product With Four Non-Combusted Cigarette Variants

Start date: November 29, 2021
Phase: N/A
Study type: Interventional

This is a single-center, open-label, randomized, 2-arm, within-arm cross-over study designed to evaluate elements of abuse liability (AL) including subjective effects and physiological measures (pharmacodynamics [PD]), and plasma nicotine uptake (pharmacokinetics [PK]) during and following ad libitum use of the study investigational products (IPs) by generally healthy smokers.